Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF -Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134
Atkins, Michael B, Lee, Sandra J, Chmielowski, Bartosz, Tarhini, Ahmad A, Cohen, Gary I, Truong, Thach-Giao, Moon, Helen H, Davar, Diwakar, O'Rourke, Mark, Stephenson, Joseph J, Curti, Brendan D, Urba, Walter J, Brell, Joanna M, Funchain, Pauline, Kendra, Kari L, Ikeguchi, Alexandra P, Jaslowski, Anthony, Bane, Charles L, Taylor, Mark A, Bajaj, Madhuri, Conry, Robert M, Ellis, Robert J, Logan, Theodore F, Laudi, Noel, Sosman, Jeffrey A, Crockett, David G, Pecora, Andrew L, Okazaki, Ian J, Reganti, Sowjanya, Chandra, Sunandana, Guild, Samantha, Chen, Helen X, Streicher, Howard Z, Wolchok, Jedd D, Ribas, Antoni, Kirkwood, John M
Published in Journal of clinical oncology (10.01.2023)
Published in Journal of clinical oncology (10.01.2023)
Get full text
Journal Article
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer
O'Donnell, Peter H, Milowsky, Matthew I, Petrylak, Daniel P, Hoimes, Christopher J, Flaig, Thomas W, Mar, Nataliya, Moon, Helen H, Friedlander, Terence W, McKay, Rana R, Bilen, Mehmet A, Srinivas, Sandy, Burgess, Earle F, Ramamurthy, Chethan, George, Saby, Geynisman, Daniel M, Bracarda, Sergio, Borchiellini, Delphine, Geoffrois, Lionnel, Maroto Rey, Jose Pablo, Ferrario, Christiano, Carret, Anne-Sophie, Yu, Yao, Guseva, Maria, Homet Moreno, Blanca, Rosenberg, Jonathan E
Published in Journal of clinical oncology (01.09.2023)
Published in Journal of clinical oncology (01.09.2023)
Get full text
Journal Article
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab
Milowsky, Matthew I, O'Donnell, Peter H, Hoimes, Christopher J, Petrylak, Daniel P, Flaig, Thomas W, Moon, Helen H, Friedlander, Terence W, Mar, Nataliya, McKay, Rana R, Srinivas, Sandy, Gravis, Gwenaelle, Ramamurthy, Chethan, Bupathi, Manojkumar, Bracarda, Sergio, Wright, Phoebe, Hepp, Zsolt, Carret, Anne-Sophie, Yu, Yao, Dillon, Ryan, Kataria, Ritesh, Beaumont, Jennifer L, Purnajo, Intan, Rosenberg, Jonathan E
Published in Journal of clinical oncology (20.04.2024)
Published in Journal of clinical oncology (20.04.2024)
Get full text
Journal Article
Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States
Moon, Helen H, Kearney, Mairead, Mahmoudpour, Seyed Hamidreza, Ike, Chiemeka, Morris, Valerie, Rava, Andrew, Kim, Sonia, Sun, Haiyan, Boyd, Marley, Gomez Rey, Gabriel
Published in Current oncology (Toronto) (21.09.2024)
Published in Current oncology (Toronto) (21.09.2024)
Get full text
Journal Article
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study
Allaf, Mohamad E, Kim, Se-Eun, Master, Viraj, McDermott, David F, Harshman, Lauren C, Cole, Suzanne M, Drake, Charles G, Signoretti, Sabina, Akgul, Mahmut, Baniak, Nicholas, Li-Ning, Elsa, Palmer, Matthew B, Emamekhoo, Hamid, Adra, Nabil, Kaimakliotis, Hristos, Ged, Yasser, Pierorazio, Phillip M, Abel, E Jason, Bilen, Mehmet A, Ogan, Kenneth, Moon, Helen H, Ramaswamy, Krishna A, Singer, Eric A, Mayer, Tina M, Lohrey, Jay, Margulis, Vitaly, Gills, Jessie, Delacroix, Scott E, Waples, Mark J, James, Andrew C, Wang, Peng, Choueiri, Toni, Michaelson, M Dror, Kapoor, Anil, Heng, Daniel Y, Shuch, Brian, Leibovich, Bradley C, Lara, Primo N, Manola, Judith, Maskens, Deborah, Battle, Dena, Uzzo, Robert, Bratslavsky, Gennady, Haas, Naomi B, Carducci, Michael A
Published in The lancet oncology (01.08.2024)
Published in The lancet oncology (01.08.2024)
Get full text
Journal Article
Real-world (rw) treatment patterns, sequencing, and outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in the US
Moon, Helen H., Kearney, Mairead, Mahmoudpour, Seyed Hamidreza, Ike, Chiemeka, Morris, Valerie A., Rava, Andrew, Kim, Sonia, Sun, Haiyan, Boyd, Marley, Gomez Rey, Gabriel
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Assessment of treatment patterns and real-world outcomes following changes in the treatment paradigm for locally advanced/metastatic urothelial carcinoma (la/mUC) in the US
Kirker, Melissa, Abraham, Anup, Vlahiotis, Anna, Bhanegaonkar, Abhijeet, Benjumea, Darrin, Kim, Chai, Sun, Haiyan, Kearney, Mairead, Chandrasekar, Sanjana, Li, Benjamin, Thakkar, Sheena, Moon, Helen H
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
A randomized phase II study of atezolizumab (atezo) plus recombinant human IL-7 (CYT107) in patients with locally advanced or metastatic urothelial carcinoma
Pachynski, Russell Kent, Chatta, Gurkamal S., Jain, Rohit K., Moon, Helen H., Sweis, Randy F., Delacroix, Scott Edward, Fang, Alana, D'amico, Leonard A., Kask, Angela Shaulov, Fling, Steven P., Lacroix, Andreanne, Kaiser, Judith C., Sharon, Elad, Yu, Evan Y.
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Real-world response rates and clinical outcomes of patients treated with first-line (1L) platinum-based chemotherapy (PBC) in advanced urothelial cancer (aUC)
Moon, Helen H, Aragon-Ching, Jeanny B., Thompson, Allison, Abraham, Anup, Vlahiotis, Anna, Ike, Chiemeka, Benjumea, Darrin, Shao, Anran, Sun, Haiyan, Kearney, Mairead, Gharibian, Norbek, Hanson, Sarah, Li, Benjamin, Kirker, Melissa, Grivas, Petros
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Baseline characteristics from a retrospective, observational, US-based, multicenter, real-world (RW) study of avelumab first-line maintenance (1LM) in locally advanced/metastatic urothelial carcinoma (la/mUC) (PATRIOT-II)
Grivas, Petros, Barata, Pedro C., Moon, Helen, Hutson, Thomas E., Gupta, Shilpa, Sternberg, Cora N., Dave, Vaidehi, Downey, Chad, Shillington, Alicia C., Devgan, Geeta, Kirker, Melissa, Thakkar, Sheena, Katzenstein, Howard M., Bhanegaonkar, Abhijeet, Liu, Frank, Brown, Jason, Sonpavde, Guru P.
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study
Choueiri, Toni K, Albiges, Laurence, Barthélémy, Philippe, Iacovelli, Roberto, Emambux, Sheik, Molina-Cerrillo, Javier, Garmezy, Benjamin, Barata, Pedro, Basu, Arnab, Bourlon, Maria T, Moon, Helen, Ratta, Raffaele, McKay, Rana R, Chehrazi-Raffle, Alexander, Hammers, Hans, Heng, Daniel Y C, Braendle, Edgar, Beckermann, Kathryn E, McGregor, Bradley A, Motzer, Robert J
Published in The Lancet (British edition) (05.10.2024)
Published in The Lancet (British edition) (05.10.2024)
Get full text
Journal Article
Avelumab first-line maintenance therapy for locally advanced/metastatic urothelial carcinoma: Results from the real-world US PATRIOT-II study
Grivas, Petros, Barata, Pedro C., Moon, Helen H., Gupta, Shilpa, Hutson, Thomas E., Sternberg, Cora N., Brown, Jason, Dave, Vaidehi, Downey, Chad, Shillington, Alicia C., Katzenstein, Howard, Kirker, Melissa, Hanson, Sarah, Liu, Frank X., Morris, Valerie A., Bhanegaonkar, Abhijeet, Sonpavde, Guru P.
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
PATRIOT II: An ambispective, observational, multicenter, 2-cohort study of avelumab (Ave) first-line maintenance (1LM) in locally advanced/metastatic urothelial carcinoma (la/mUC) in the United States
Grivas, Petros, Barata, Pedro C., Moon, Helen, Hutson, Thomas E., Gupta, Shilpa, Sternberg, Cora N., Pickard, A. Simon, Dave, Vaidehi, Han, Natalia, Shillington, Alicia C., Devgan, Geeta, Kim, Ruth, Thakkar, Sheena, Katzenstein, Howard, Bhanegaonkar, Abhijeet, Liu, Frank, Sonpavde, Guru P.
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Enfortumab vedotin (EV) with or without pembrolizumab (P) in patients (pts) who are cisplatin-ineligible with previously untreated locally advanced or metastatic urothelial cancer (la/mUC): Additional 3-month follow-up on cohort K data
Friedlander, Terence W., Milowsky, Matthew I., O'Donnell, Peter H., Petrylak, Daniel P., Hoimes, Christopher J., Flaig, Thomas W., Mar, Nataliya, Moon, Helen H, McKay, Rana R., Bilen, Mehmet Asim, Borchiellini, Delphine, Iafolla, Marco, Carret, Anne-Sophie, Yu, Yao, Guseva, Maria, Kataria, Ritesh S., Rosenberg, Jonathan E.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Patient-reported outcomes (PROs) in cisplatin-ineligible patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC) treated with enfortumab vedotin (EV) alone or in combination with pembrolizumab (P) in the phase 1b/2 EV-103 Cohort K study
Milowsky, Matthew I., O'Donnell, Peter H., Hoimes, Christopher J., Petrylak, Daniel P., Flaig, Thomas W., Moon, Helen H, Friedlander, Terence W., Mar, Nataliya, McKay, Rana R., Srinivas, Sandy, Gravis, Gwenaelle, Ramamurthy, Chethan, Bupathi, Manojkumar, Bracarda, Sergio, Wright, Phoebe, Carret, Anne-Sophie, Yu, Yao, Matsuda, Tara, Kataria, Ritesh S., Rosenberg, Jonathan E.
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Enfortumab vedotin (EV) alone or in combination with pembrolizumab (P) in previously untreated cisplatin-ineligible patients with locally advanced or metastatic urothelial cancer (la/mUC): Subgroup analyses of confirmed objective response rate (cORR) from EV-103 cohort K
O'Donnell, Peter H., Rosenberg, Jonathan E., Hoimes, Christopher J., Petrylak, Daniel P., Milowsky, Matthew I., McKay, Rana R., Srinivas, Sandy, Friedlander, Terence W., Ramamurthy, Chethan, Bilen, Mehmet Asim, Burgess, Earle F, Mar, Nataliya, Moon, Helen, Geynisman, Daniel M., George, Saby, Carret, Anne-Sophie, Yu, Yao, Guseva, Maria, Homet Moreno, Blanca, Flaig, Thomas W.
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
Apolo, Andrea B, Ballman, Karla V, Sonpavde, Guru, Berg, Stephanie, Kim, William Y, Parikh, Rahul, Teo, Min Yuen, Sweis, Randy F, Geynisman, Daniel M, Grivas, Petros, Chatta, Gurkamal, Reichert, Zachery Roger, Kim, Joseph W, Bilen, Mehmet Asim, McGregor, Bradley, Singh, Parminder, Tripathi, Abhishek, Cole, Suzanne, Simon, Nicholas, Niglio, Scot, Ley, Lisa, Cordes, Lisa, Srinivas, Sandy, Huang, Jiaoti, Odegaard, Meagan, Watt, Colleen, Petrylak, Daniel, Hoffman-Censits, Jeannie, Wen, Yujia, Hahn, Olwen, Mitchell, Cecilia, Tan, Alan, Streicher, Howard, Sharon, Elad, Moon, Helen, Woods, Michael, Halabi, Susan, Perez Burbano, Gabriela, Morris, Michael J, Rosenberg, Jonathan E
Published in The New England journal of medicine (15.09.2024)
Published in The New England journal of medicine (15.09.2024)
Get more information
Journal Article
Avelumab first-line maintenance for locally advanced or metastatic urothelial carcinoma: results from the real-world US PATRIOT-II study
Grivas, Petros, Barata, Pedro, Moon, Helen, Gupta, Shilpa, Hutson, Thomas, Sternberg, Cora N., Brown, Jason R., Dave, Vaidehi, Downey, Chad, Shillington, Alicia C., Katzenstein, Howard M., Kirker, Melissa, Hanson, Sarah, Liu, Frank X., Morris, Valerie, Bhanegaonkar, Abhijeet, Sonpavde, Guru P.
Published in Clinical genitourinary cancer (01.10.2024)
Published in Clinical genitourinary cancer (01.10.2024)
Get full text
Journal Article
Immune-related adverse events (IRAE) of elderly patients (PTS) with advanced melanoma (AMEL) treated with checkpoint inhibitors (CI) in a community setting: The experience (EXP) at Kaiser Permanente (KP) California
Truong, Thach-Giao, Moon, Helen, Chiu, Timothy, Yamamoto, Christopher, Spence, Michele M., Kavecansky, Juraj, Niu, Fang, Hui, Rita L.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article